Your search returned 6 results.

Results
	1.	Bioresorbable polymer drug-eluting stents - Authors' reply. MedStar authors: Waksman, Ron PMID: 29536855 Year: 2018 Citation: Lancet. 391(10124):936-937, 2018 Mar 10 Institution: MedStar Heart & Vascular Instituteon Medline publication type: Letter Form of publication: Journal Article All authors: Doros G, Kandzari DE, Koolen JJ, Mauri L, Waksman R DOI: https://dx.doi.org/10.1016/S0140-6736(18)30535-X Add to cart (remove)
	2.	What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?. [Review] MedStar authors: Weintraub, William S PMID: 35033221 Year: 2022 Citation: Lancet. 399(10325):691-694, 2022 02 12. Institution: MedStar Health Research Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Al-Lamee R, Boden WE, Kaski JC, Weintraub WS DOI: https://dx.doi.org/10.1016/S0140-6736(21)02045-6 Add to cart (remove)
	3.	Delayed consent: will there be a shift in approach for US primary percutaneous coronary intervention trials?. [Review] MedStar authors: MacKay, Charles R Torguson, Rebecca Waksman, Ron PMID: 25960111 Citation: Lancet. 386(9994):714-6, 2015 Aug 15. Institution: MedStar Health Research Institute MedStar Heart & Vascular Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: MacKay CR, Torguson R, Waksman R DOI: http://dx.doi.org/10.1016/S0140-6736(15)60077-0 Add to cart (remove)
	4.	Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. MedStar authors: Garcia-Garcia, Hector M Waksman, Ron PMID: 28851504 Year: 2017 Citation: Lancet. 390(10105):1843-1852, 2017 Oct 21. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Roguin A, Waksman R DOI: https://dx.doi.org/10.1016/S0140-6736(17)32249-3 Add to cart (remove)
	5.	Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. MedStar authors: Waksman, Ron PMID: 26470647 Year: 2016 Citation: Lancet. 387(10013):31-9, 2016 Jan 2. Institution: MedStar Heart & Vascular Institute Medline publication type: Clinical Study Journal Article Multicenter Study Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Abizaid A, Christiansen EH, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Ince H, Kaiser C, Lemos PA, Lim ST, Neumann FJ, Toelg R, von Birgelen C, Waksman R, Wijns W DOI: http://dx.doi.org/10.1016/S0140-6736(15)00447-X Add to cart (remove)
	6.	Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study. MedStar authors: Brewer, H Bryan Craig, Paige E Garcia-Garcia, Hector M Kolm, Paul Torguson, Rebecca Waksman, Ron Zou, Quan PMID: 31570255 Year: 2019 Citation: Lancet. 394(10209):1629-1637, 2019 11 02. Institution: MedStar Health Research Institute MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Ali ZA, Artis AK, Brewer HB, Cate TT, Craig PE, Di Mario C, Dube S, Garcia-Garcia HM, Kazziha S, Kim C, Kolm P, Lewis S, LRP Investigators, Powers E, Regar E, Shah P, Singh V, Skinner WH, Torguson R, van der Ent M, Waksman R, Wong SC, Wykrzykowska J, Zou Q DOI: https://dx.doi.org/10.1016/S0140-6736(19)31794-5 Add to cart (remove)

Powered by Koha